apomorphine (Renown Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameapomorphine (Renown Pharma)
Drug Alias Nameapomorphine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A